Published by Becker’s Healthcare, March 2026 | Author: Aspirion
The Real Source of Rising Denial Rates
Despite investments in Clinical Documentation Improvement programs, clinical denial rates keep climbing—not because of documentation failures, but because payers have deployed machine learning systems to conduct retrospective audits at a scale no human team can match. Payers are quietly reducing prior authorization requirements while expanding post-payment record reviews, shifting the evidentiary burden entirely onto providers after care has already been delivered.
The Hidden Revenue Bleed
Outright denials are only part of the problem. The American Hospital Association reported $130 billion in Medicare and Medicaid underpayments in 2023 alone. These don’t appear as denials—they close as zero-balance accounts and vanish from view, never triggering a follow-up workflow.
Why Traditional Appeals Processes Fall Short
Building a defensible clinical appeal requires expertise spanning documentation analysis, clinical guidelines, payer policy, and legal argumentation. Historically, around 60% of denied claims went uncontested — not because providers couldn’t win, but because assembling that expertise cost more than the claim was worth. Payers built their audit strategies around exactly that threshold.
How AI Changes the Economics
Purpose-built AI platforms can ingest denial correspondence, validate evidence against clinical guidelines, and produce structured appeal drafts at scale. Aspirion reports AI-assisted appeals achieved a 30% gain in medical record review productivity, a 40-day reduction in placement-to-payment, and overturn rates improving by more than 10%. On the underpayment side, AI contract modeling can surface payment variances that manual review would never reach.
The Bottom Line
This is fundamentally an information-processing competition. With unknown and underworked denials representing 54% of total recovery opportunity, and providers losing an estimated 1–7% of net revenue annually, the scale of exposure has simply been normalized. For health systems operating on thin margins, the only viable path to full revenue recovery pairs AI-driven analysis with clinical and legal expertise across the entire spectrum of revenue at risk.
Read the full article here.